Global Generic Drugs Market 2023-2029

March 2023 | 81 pages | ID: G14CA3FDBE2CEN
Gen Consulting Company

Abstracts

According to the latest data, the market size of the global generic drugs sector is expected to rise by USD 226.3 billion with a CAGR of 7.2% by the end of 2029.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global generic drugs market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the route of administration, application, end user, and region. The global market for generic drugs can be segmented by route of administration: injectable, oral, topical, others. The oral segment is estimated to account for the largest share of the global generic drugs market. Generic drugs market is further segmented by application: anti-cancer drugs, anti-infectives, cardiovascular products, central nervous system (CNS) drugs, drugs for arthritis, respiratory products, others. The cardiovascular products segment held the largest revenue share in 2022. Based on end user, the generic drugs market is segmented into: hospitals and clinics, retail pharmacies, others. Globally, the retail pharmacies segment made up the largest share of the generic drugs market. On the basis of region, the generic drugs market also can be divided into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. Asia-Pacific was the largest contributor to the global generic drugs market in 2022.

Market Segmentation

By route of administration: injectable, oral, topical, others

By application: anti-cancer drugs, anti-infectives, cardiovascular products, central nervous system (CNS) drugs, drugs for arthritis, respiratory products, others

By end user: hospitals and clinics, retail pharmacies, others

By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The report has also analysed the competitive landscape of the global generic drugs market with some of the key players being Aspen Pharmacare Holdings Limited, Abbott Laboratories, AbbVie Inc., Aurobindo Pharma Limited, Baxter International Inc., Cipla Limited, Eli Lilly and Company, Fresenius Kabi AB, GlaxoSmithKline plc, Hikma Pharmaceuticals plc, Lupin Limited, Mylan N.V., Novartis AG, Pfizer Inc., Sanofi S.A., STADA Arzneimittel AG, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Limited, among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Scope of the Report

• To analyze and forecast the market size of the global generic drugs market.
• To classify and forecast the global generic drugs market based on route of administration, application, end user, region.
• To identify drivers and challenges for the global generic drugs market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global generic drugs market.
• To identify and analyze the profile of leading players operating in the global generic drugs market.

Why Choose This Report

• Gain a reliable outlook of the global generic drugs market forecasts from 2023 to 2029 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints

PART 5. MARKET BREAKDOWN BY ROUTE OF ADMINISTRATION

Injectable
Oral
Topical
Others

PART 6. MARKET BREAKDOWN BY APPLICATION

Anti-cancer drugs
Anti-infectives
Cardiovascular products
Central nervous system (CNS) drugs
Drugs for arthritis
Respiratory products
Others

PART 7. MARKET BREAKDOWN BY END USER

Hospitals and clinics
Retail pharmacies
Others

PART 8. MARKET BREAKDOWN BY REGION

North America
Europe
Asia-Pacific
MEA (Middle East and Africa)
Latin America

PART 9. KEY COMPANIES

Aspen Pharmacare Holdings Limited
Abbott Laboratories
AbbVie Inc.
Aurobindo Pharma Limited
Baxter International Inc.
Cipla Limited
Eli Lilly and Company
Fresenius Kabi AB
GlaxoSmithKline plc
Hikma Pharmaceuticals plc
Lupin Limited
Mylan N.V.
Novartis AG
Pfizer Inc.
Sanofi S.A.
STADA Arzneimittel AG
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Limited
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER